Albert Invent raises $55 million Series B at $340 million valuation after debuting AI model trained on chemical patents and 15 million molecules.
| Source: Techmeme | Original article
Albert Invent, whose AI model trained on chemical patents and 15 M molecules, secured a $55 M Series B round, valuing the company at $340 M, with scientists at Kenvue and Henkel using its tools.
Albert Invent, a startup that has built an artificial‑intelligence model trained on chemical‑patent literature and a database covering roughly 15 million molecules, has closed a $55 million Series B financing round, a source told Forbes. The funding values the company at about $340 million and is expected to accelerate product development and expand its go‑to‑market effort.
The raise is notable because Albert Invent’s platform promises to speed up the discovery and optimisation of chemical compounds by allowing scientists to query a vast, curated knowledge base with natural‑language prompts. Early adopters such as scientists at manufacturing conglomerates Kenvue and Henkel are already using the tools to explore formulation alternatives and assess patent landscapes, suggesting the technology is moving beyond academic proof‑of‑concept into industrial R&D pipelines.
The infusion of capital comes at a time when investors are increasingly betting on specialised AI models that address niche, high‑value domains. By focusing on chemistry, Albert Invent sidesteps the broader, data‑intensive models that dominate the market and instead offers a targeted solution for sectors where intellectual‑property risk and molecular complexity are critical.
Going forward, observers will watch how the company leverages the new funds to broaden its molecule database, integrate with enterprise workflows, and potentially partner with larger chemical or pharmaceutical firms. The next milestones to monitor are any announced collaborations, product releases that extend beyond the current patent‑search use case, and signs of adoption by additional manufacturers seeking AI‑driven acceleration of their chemistry programs.
Sources
Back to AIPULSEN